The Sustained Release Excipients Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of sustained release excipients has experienced significant growth recently. It was at $1.4 billion in 2024, and it is projected to rise to $1.53 billion in 2025. This growth represents a compound annual growth rate (CAGR) of 9.1%.
The Sustained Release Excipients Global Market is projected to reach $2.13 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.8%.
Download Your Free Sample of the 2025 Sustained Release Excipients Market Report and Uncover Key Trends Now!The key drivers in the sustained release excipients market are:
• Increasing geriatric population
• Increased focus on personalized medicine
• Challenges in patient adherence
• Rise in complex drug formulations
The sustained release excipients market covered in this report is segmented –
1) By Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan
2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration
3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation
The key trends in the sustained release excipients market are:
• There is a focus on personalized medicine as a key trend for the future.
• Collaborations for formulation development are increasingly becoming a trend.
• Maintaining regulatory compliance and safety is an emerging trend.
• The influence of biopharmaceuticals is increasingly shaping the market.
The major players in the sustained release excipients market are:
• BASF SE
• Ashland Global Holdings Inc
North America was the largest region in the global sustained release excipients market in 2024